Knee Pain Clinical Trial
Official title:
Effect of Oleuropein-based Dietary Supplement (Bonolive™) Versus Placebo on Knee Joint Functionality and Cartilage Catabolism in Ageing Population
NCT number | NCT03072108 |
Other study ID # | 15.16.CLI |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 24, 2016 |
Est. completion date | April 30, 2018 |
Verified date | October 2018 |
Source | Nestlé |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical study evaluates if the oral administration of Bonolive can contribute to the improvement of functionnality in healthy elderly people with knee discomfort.
Status | Completed |
Enrollment | 124 |
Est. completion date | April 30, 2018 |
Est. primary completion date | April 30, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 55 Years and older |
Eligibility |
Inclusion Criteria: - Male or female = 55 years of age - BMI between 18.5 and 29.9 kg/m2 (normo and overweight) - Moderate knee pain (the most painful knee is considered) - Able to follow the instructions of the study - Able to perform physical tests - Having signed an informed consent Exclusion Criteria: Related to knee - Recent trauma (< 1 month) of the knee responsible of the symptomatic knee - Subject with knee/joint surgery/replacement and ACL (Cross Ligament) injury in the target knee - Concurrent articular disease interfering with the evaluation of pain such as articular dysplasia, aseptic osteonecrosis, acromegaly, Paget's disease, hemophilia, hemochromatosis, chondromatosis, villonodular synovitis of the knee, seronegative spondyloarthropathy, rheumatoid arthritis, gouty arthritis , infectious arthritis, radiculalgia in the lower limbs, arteritis - Prosthesis in the target knee - Diagnosed arthrosis eligible to knee/joint surgery/replacement Related to treatments - Analgesics to manage knee pain 24h before inclusion visit - Corticosteroids injection in the target knee in the month preceding inclusion - Hyaluronan injection in the target knee in the last 6 months - Oral corticotherapy = 5mg/day in the last 3 months - Symptomatic slow-acting drugs (SYSADs) treatment (Chondroitin, diacerein, glucosamine, soy and avocado unsaponifiables) in the last 3 months - Other dietary supplements used for articular disorders in the last 3 months - An anticipated need for the duration of the trial of corticosteroids or hyaluronan injection, oral corticotherapy, arthroscopy, analgesics other than listed as rescue treatments, which are forbidden during the trial - Arthroscopy in the last 6 months - Allergy or contra-indication to Oleuropein, to maltodextrin or any ingredient present in the product, or intolerance to rescue treatment (Paracetamol and NSAIDs) - Treatments based on strontium ranelate, bisphosphonates, selective estrogen-receptor modulator (SERM) and parathormone (PTH) during the year before inclusion Related to associated diseases - Severe and uncontrolled diseases (liver or renal failure, lung/heart severe disease, Parkinson, progressive malignant neoplasia or in remission for less than 5 years, HIV, etc.) - Lower or upper extremity surgery or fracture in the last 3 months - Anticipated need for any surgical or other invasive procedure during the trial including prosthesis in the target knee - Swallowing disorder Related to patients - Close collaborators to the investigational team, the study coordinator (Artialis) or to the Sponsor (Nestlé) - Currently participating or having participated in another therapeutic clinical trial in the three previous months - Having made a blood donation in the past month - Under guardianship or judicial protection - Pregnancy, breastfeeding, planned conception - Premenopausal women or women without tubal ligation or contraception. |
Country | Name | City | State |
---|---|---|---|
Belgium | Centre Hospitalier Universitaire de Liège | Liege |
Lead Sponsor | Collaborator |
---|---|
Nestlé | Artialis |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Evaluation of food habits and frequency using patient-reported questionnaire | From the date of inclusion until end of study, on a monthly basis, up to 6 months | ||
Primary | Evaluation of the effect of investigational product after 6 months of supplementation | KOOS (Knee injury and Osteoarthritis Outcome Score) | From Baseline to 6 months of product administration and compared to Placebo | |
Primary | Evaluation of the effect of investigational product after 6 months of supplementation | Biomarker of cartilage breakdown (Coll2.1-NO2) | From Baseline to 6 months of product administration and compared to Placebo | |
Secondary | Evaluation of the effect of investigational product | Knee pain VAS score at rest and at walking | From Baseline to 6 months of product administration and compared to Placebo | |
Secondary | Evaluation of the effect of investigational product | OARSI core set of performance-based tests | From Baseline to 6 months of product administration and compared to Placebo |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02873143 -
5 Year Follow-up of Adolescents With Knee Pain
|
N/A | |
Completed |
NCT00752765 -
The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the Knee
|
N/A | |
Recruiting |
NCT05674604 -
Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting
|
||
Terminated |
NCT03171168 -
The Effect of AposTherapy on Knee Pain
|
N/A | |
Completed |
NCT05221047 -
A Reliability and Validity Study of Urdu Version of Knee Outcome Survey-Activities of Daily Living Scale
|
||
Terminated |
NCT01351558 -
Exercise and Pain Sensitivity
|
N/A | |
Terminated |
NCT00601341 -
Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response
|
N/A | |
Completed |
NCT03969654 -
ROSA Robot Used in Total Knee Replacement Post Market Study
|
N/A | |
Completed |
NCT03910036 -
Effect of PRP Injection After Arthroscopic Meniscal Repair in the Healing Process
|
Phase 4 | |
Terminated |
NCT01764139 -
Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes
|
N/A | |
Withdrawn |
NCT01112319 -
The Effects of the Electro, Heat and Cold -Therapy During Physiotherapy Treatment in Osteoarthritis(OA) of KNEE
|
Phase 1 | |
Completed |
NCT00662493 -
A Comparison of Two Exercise Programs on Knee Motor Control
|
Phase 2 | |
Completed |
NCT03956875 -
Yoga for Aromatase Inhibitor-related Knee Pain Relief in Breast Cancer Patients
|
N/A | |
Completed |
NCT00923598 -
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
|
Phase 4 | |
Terminated |
NCT03970629 -
ROSA Total Knee Investigational Testing Authorization Study
|
N/A | |
Completed |
NCT00403273 -
Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA)
|
Phase 2 | |
Completed |
NCT00745069 -
Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis
|
Phase 2 | |
Completed |
NCT03815448 -
Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis
|
N/A | |
Recruiting |
NCT04084236 -
The Effects of Transcutaneous Electrical Nerve Stimulation on People With Knee Osteoarthritis (OA) and or Chronic Pain
|
N/A | |
Completed |
NCT05470244 -
TENS in Post-operative Total Knee Arthroplasty Recovery and Intra-venous Analgesics Requirement
|
N/A |